Advertising
Showing 1 to 15 of 79 entries
BUY
Biggest manufacturer of syringes in the world. It is a large business with multiple moving parts so they have been range bound for the last little while. He likes their opportunities to generate cash flow and so it is a good name to hold.
Healthcare
HOLD
Big medical supplies. They also have some proprietary parts of the business. He sold it about a month ago to buy one of today's top picks. You won't do too badly owning this going forward.
Healthcare
PAST TOP PICK
(A Top Pick Apr 21/20, Down 4%) Hurt during Covid by surgeries not being performed. Should have a strong 2021.
Healthcare
HOLD
He has no plans to sell it. They were very strong last year. It has been a little slow this year. You are not going to have explosive growth every single year. You might want to watch it and buy it if it dips coming out of the pandemic.
Healthcare
WAIT
Syringes, IVs, disposable items. On his hot watch list. He's looking at hospital utilization rates. The market is waiting too. Once rates tick up, they'll be a direct beneficiary.
Healthcare
WATCH
90% of the things they make are disposables. They make syringes among other things. The products are diversified and one does not dominate their revenues. There are many operations that should have happened but have not due to covid. Earnings will accelerate once covid has subsided and procedures restart.
Healthcare
WATCH
90% of the things they make are disposables. They make syringes among other things. The products are diversified and one does not dominate their revenues. There are many operations that should have happened but have not due to covid. Earnings will accelerate once covid has subsided and procedures restart.
Healthcare
TOP PICK

"Canadian Tire" of healthcare products for clinics and medical offices. Products are one-use only. Elective surgeries have been cancelled, so stock has not done much. Will shine in post-Covid era. Yield is 1.38%. (Analysts’ price target is $272.31)

Healthcare
BUY

Healthcare gets knocked down before an election so there is a constant battle at this time of year and then it disappears after the election. This is a great company and continues to do well and you should own it or SYK-N, which he owns.

Healthcare
DON'T BUY

BDX vs. BSX Owns Boston Scientific instead, with a strong history of execution. One-time events threw off that execution. Hospital procedures are coming back, which will benefit the entire industry. BSX is better known for innovation.

Healthcare
BUY
A medical products company. They had a recall of one of their products this year, and they were late on the ball with covid testing. Now that things are open again and people are going to the hospital, they should have a positive outlook.
Healthcare
BUY
A good opportunity. Covid has led to deferral of elective surgeries, so revenues are suffering and the market didn't like this. Vaccine testing will help them quite a bit to monetize their testing technology. Reasonable opportunity. Wouldn't be shy to buy at these levels.
Healthcare
BUY
Allan Tong’s Discover Picks The pandemic helped BDX, since most of its products are disposable. Then again, during the spring lockdown, surgeries were cancelled across the board, so use of BDX's products nearly halted. Its chart this year has been rocky, though earlier this month, the stock returned to previous highs above $280 while it has met or narrowly beat its EPS in the past four quarters. BDX continues to be profitable at a margin of 7.13% and a 15.41% five-year average revenue growth. Forward PE stands at 20.44x and it pays a dividend of 1.2%. Read BDX, BSX, ISRG and Stryker Stock: Top 4 Medical Supply Stocks for our full analysis.
Healthcare
BUY
One of the better US healthcare companies, making needles and test tubes. BDX has done very well in recent years though flat during COVID, so he expects a catch-up. No reason to be afraid of this. It's a solid stock that will grow 3-5% annually.
Healthcare
PAST TOP PICK
(A Top Pick Jun 24/19, Up 12%) The only company that can manufacture disposable, consumable medical products, especially syringes. They benefit from the pandemic and will benefit from the aging population.
Healthcare
Showing 1 to 15 of 79 entries

Becton Dickinson(BDX-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Becton Dickinson is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Becton Dickinson(BDX-N) Frequently Asked Questions

What is Becton Dickinson stock symbol?

Becton Dickinson is a American stock, trading under the symbol BDX-N on the New York Stock Exchange (BDX). It is usually referred to as NYSE:BDX or BDX-N

Is Becton Dickinson a buy or a sell?

In the last year, 4 stock analysts published opinions about BDX-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Becton Dickinson.

Is Becton Dickinson a good investment or a top pick?

Becton Dickinson was recommended as a Top Pick by on . Read the latest stock experts ratings for Becton Dickinson.

Why is Becton Dickinson stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Becton Dickinson worth watching?

4 stock analysts on Stockchase covered Becton Dickinson In the last year. It is a trending stock that is worth watching.

What is Becton Dickinson stock price?

On 2021-11-30, Becton Dickinson (BDX-N) stock closed at a price of $236.71.